ALFA Filings
Every announcement, straight from the exchange
Every Marksans Pharma acquisition announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Marksans Pharma Ltd has completed the acquisition of QliniQ B.V., obtaining 100% share capital. The transaction expands Marksans' presence in the Netherlands.
Marksans Pharma acquired 100% of Netherlands-based QliniQ B.V. for ₹82.98 Crore. The deal strengthens its European distribution and marketing infrastructure for Indian-manufactured products.
Marksans Pharma is acquiring 100% of Netherlands-based QliniQ B.V. for ₹71.25 Crore. The deal strengthens Marksans' European distribution and forward-integration strategy.